Changes in Serum Calcium and Treatment of Hypoparathyroidism During Pregnancy and Lactation: A Single-center Case Series
- 19 July 2021
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (12) , e5054-e5063
Abstract
Background Hypoparathyroidism (hypo-PT) is rare, and studies on hypo-PT, especially during pregnancy and lactation, are limited. Design and Setting This was a retrospective study on a relatively large case series in a single center from mainland China. Methods A total of 19 patients with 25 pregnancies, diagnosed with hypo-PT before pregnancy, were enrolled. Data on clinical characteristics and treatment strategies at onset time and around pregnancy period were collected. Results During pregnancy, except for 2 patients with missing data, 5 patients with 6 pregnancies (6/23, 26.1%) experienced improved hypo-PT condition, defined as an increased serum calcium level; 4 patients with 4 pregnancies (4/23, 17.4%) experienced worsened hypo-PT condition, defined as a more than 0.2 mmol/L decline in the serum calcium level; and 3 patients with 3 pregnancies (3/23, 13.0%) remained in stable hypo-PT condition. The prevalence of adverse pregnancy outcomes was 30.4% (4/23 for preterm delivery; 3/23 for miscarriage). The serum calcium and 24-hour urine calcium levels significantly increased during lactation compared with pregnancy (2.57 ± 0.34 vs 1.99 ± 0.11 mmol/L, P < 0.001; 12.28 ± 5.41 vs 8.63 ± 3.22 mmol/L, P = 0.013), and 5 patients with 5 lactations (5/12, 41.7%) developed hypercalcemia in the first 2 months after delivery. Conclusions Female patients with hypo-PT had different changes in calcium homeostasis and a high prevalence of adverse outcomes during pregnancy. Thus, they should be monitored closely to maintain the optimal serum calcium level. Decreasing drug dosage during the lactation period should be considered to avoid hypercalcemia.Keywords
Funding Information
- National Natural Science Foundation of China (81873641, 82070817)
- Chinese Academy of Medical Sciences
- Innovation Fund for Medical Sciences (2017-I2M-1-001)
This publication has 23 references indexed in Scilit:
- Changes in calcitropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort studyOsteoporosis International, 2012
- Hypoparathyroidism in pregnancyGynecological Endocrinology, 2010
- HypoparathyroidismNew England Journal of Medicine, 2008
- Successful Outcome of Pregnancy Complicated with Thyroidectomy – Induced Hypoparathyroidism and Sudden DyspneaGynecologic and Obstetric Investigation, 1993
- Intestine, Bone, and Mammary Gland Contributions to Maternal Plasma Calcium Increase after Abrupt WeaningExperimental Biology and Medicine, 1992
- Thyroid and parathyroid-independent increase in plasma 1,25-dihydroxyvitamin D during late pregnancy in the ratJournal of Endocrinology, 1988
- REMISSION OF HYPOPARATHYROIDISM DURING LACTATION: EVIDENCE FOR A PHYSIOLOGICAL ROLE FOR PROLACTIN IN THE REGULATION OF VITAMIN D METABOLISMClinical Endocrinology, 1987
- Plasma Calcium Control in the Rat Fetus. I. Influence of Maternal HormonesNeonatology, 1985
- Maternal-Fetal Relationships in the Parathyroidectomized RatNeonatology, 1984
- Fetal growth and 1,25-dihydroxyvitamin D3 injections into thyroparathyroidectomized pregnant ratsReproduction Nutrition Développement, 1981